Methodology

DNA sequencing of the coding regions and introns of both the alpha1 (HBA1) and alpha 2 globin (HBA2) genes in both directions to detect point mutations causing alpha globin variants and some types of alpha thalassemia.

This test detects alpha globin variants and non-deletional alpha thalassemia mutations (e.g. Hb Constant Spring). The coding regions and introns of both HBA1 and HBA2 genes are sequenced in bidirectionally. The reference mRNA sequences are HBA1 (NM_000558.3) and HBA2 (NM_000517.4) with nucleotide 1 corresponding to the A of the AUG initiation codon (nucleotide 38 of both reference sequences) and codon 1 corresponding to the valine encoded by GTG (nucleotides 41-43 of both reference sequences). The sensitivity of this test for detecting nucleotide substitutions, small insertions and deletions and in the alpha 1 (HBA1) and alpha 2 (HBA2) genes is theoretically >98%. This test will not detect mutations that lie outside of the sequenced regions, nor large HBA1 and HBA2 gene deletions (e.g. –a3.7, – –SEA). This test was developed and its performance characteristics determined by the Department of Laboratory Medicine at the University of Washington.